Analysis of p53 transactivation through high-affinity binding sites

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• The p53 protein is a critical tumor suppressor frequently altered in human cancers.
• Wild-type p53 exhibits growth-inhibitory effects and acts as a transcriptional regulator.
• Mutations in p53 are common in carcinogenesis, leading to loss of function.

Purpose of the Study:

• To investigate the DNA binding and transactivation (TA) properties of wild-type and mutant p53 proteins.
• To determine how viral oncoproteins affect p53's DNA binding and TA capabilities.
• To understand the role of p53 in transcriptional regulation during carcinogenesis.

Main Methods:

• DNA-gel retardation assays to detect p53-DNA complexes using radiolabelled oligonucleotides.
• Transactivation assays using a CAT reporter gene driven by the TK promoter.
• Co-transfection experiments in p53-null cells (SKOV3) and transformed cell lines (COS-1, 293).
• Analysis of p53 interactions with SV40 T-antigen and Adenovirus 5 E1B protein.

Main Results:

• Wild-type p53 demonstrated strong transactivating effects on the reporter gene.
• Most p53 mutants, except His273, were inactive in transactivation assays.
• SV40 T-antigen and Ad5 E1B protein did not interfere with p53's DNA binding or transactivation.
• Endogenous p53 in transformed cells retained wild-type DNA binding and transactivation properties.

Conclusions:

• Wild-type p53 is an efficient transactivator of the high-affinity binding site (HBS) motif.
• The His273 mutant retained some transactivation capacity.
• Transformed cells can harbor functional p53, and inactive mutants do not inhibit wild-type p53 activity.